Mymetics Corp (MYMX)

[Work Harder]

Declaration of Helsinki and Good Clinical Practice

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0055438

Geert Leroux-Roels,Cathy Maes,Frédéric Clement,Frank van Engelenburg,Marieke van den Dobbelsteen,Michael Adler,Mario Amacker,Lucia Lopalco,Morgane Bomsel,Anick Chalifour,Sylvain Fleury